TLX
TELIXPHARM FPO [TLX]
Healthcare · ASX Small Cap
$12.3900 +5.9%
Updated 19 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +0First seen: 2026-02-25
Score Breakdown
Technical68
Catalyst81
Sentiment50
Fundamental98
Momentum41
Risk Gate48
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Pressing against the upper Bollinger Band — extended and may need to cool off
- Trading above both moving averages — the trend is your friend here
- Just broke above 20-day resistance — a level that was capping price, now cleared
- On a tear — up 10.3% over the last 5 days
- Beating the Small Ords index — relative strength of 1.47, so it's outpacing the pack
- Strong cash runway (33 quarters)
- Low P/S ratio (4.9x)
- Strong revenue growth (+49%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (16% of range)
- New substantial holder(s) (2)
- Very high short interest (15.1%)
- CANSLIM I: Institutional ownership (21%)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 64% over the past year
- Revenue growing at +49% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (0.42%/day)
- Days to cover very high (14.8)
- Short squeeze potential (15.1% short + catalyst + momentum)
- Beneish M-Score -1.68 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Stochastic is stretched into overbought — could need a breather
- Below the 200-day average — the long-term trend is still working against it
- Negative profit margins (-1%)
- Not enough chatter to gauge sentiment — defaulting to neutral
Recent Catalysts
NONE Appendix 3Y Change in Director Interests - C Behrenbruch
NONE Notification of cessation of securities - TLX
NONE Telix Resubmits NDA to FDA for Pixclara Brain Cancer Imaging
HIGH Becoming a substantial holder
HIGH Becoming a substantial holder from CGF
Recent ASX Announcements
| 2026-03-17 | Appendix 3Y Change in Director Interests - C Behrenbruch |
| 2026-03-17 | Notification of cessation of securities - TLX |
| 2026-03-17 | Becoming a substantial holder |
| 2026-03-15 | Telix Resubmits NDA to FDA for Pixclara Brain Cancer Imaging PRICE SENSITIVE |
| 2026-03-12 | Becoming a substantial holder from CGF |
Key Metrics
$4.0B
Market Cap
3.4M
Avg Volume
0.9x
Vol Ratio
$8.26 — $29.72
52-Week Range
15.1%
Short Interest
N/A
Cash Runway
-1.9%
ROE
-0.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 80% |
| L | Leader vs Laggard | pass | RS: 2 |
| I | Institutional Sponsorship | pass | Inst: 21% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #28 of 118 · Sector avg: 37
View all Healthcare signals →